Abiopharma

HONEYWELL TO HOST 2026 UPDATE CALL AND INTRODUCE OUTLOOK FOR HONEYWELL TECHNOLOGIES (REMAINCO) ON MONDAY, JUNE 8

NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026

IMFINZI® (durvalumab) plus IMJUDO® (tremelimumab-actl) combined with lenvatinib and TACE reduced the risk of disease progression or death by 30% in embolization-eligible unresectable liver cancer in EMERALD-3 Phase III trial

Ten-League International Holdings Limited Regains Compliance with Nasdaq Bid Price Requirement

Solid Biosciences to Participate at Upcoming Investor Conferences

Palladyne AI Appoints Retired Lieutenant General Sean Bernabe and Retired Brigadier General Gwyn Armfield to Defense Advisory Board

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

Viasat Selected by Lockheed Martin to Support NOAA Next-Generation Aircraft with Hybrid Satellite Communications Platform

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

OpenPayd Targets Nasdaq Listing at Unicorn Valuation